Topband Marks 30 Years: From Local Controller Manufacturer to Global Intelligent Solutions Partner
SHENZHEN, China, Feb. 10, 2026 /PRNewswire/ -- Shenzhen Topband Co., Ltd. (Stock Code: 002139.SZ) marks its 30th anniversary, reflecting three decades of evolution that mirrors the broader transformation of Chinese manufacturing — from domestic...
GCCL and Medicover Integrated Clinical Services Announce Strategic Collaboration to Strengthen Multinational Clinical Trial Services
YONGIN, South Korea, Feb. 10, 2026 /PRNewswire/ -- GCCL Co., Ltd. (GCCL), a data-driven clinical trial services provider, and Medicover Integrated Clinical Services (MICS), part of Medicover, an international healthcare and diagnostic services...
Securityone Strengthens Regional Security Capabilities with Advanced Radar-Based Motion Detection and Strategic Technology Partnerships
SINGAPORE, Feb. 10, 2026 /PRNewswire/ -- Securityone Distribution Centre Pte. Ltd. continues to strengthen its role as a trusted security solutions provider by advancing its technology capabilities and expanding its portfolio of high-performance...
DeskIn Redefines Remote Desktop for Families: Bridging Distances with One Click, Delivering Boundless Care
SINGAPORE, Feb. 10, 2026 /PRNewswire/ -- DeskIn, the flagship remote access software from Zuler Technology Pte. Ltd, is designed to make everyday family support simple, secure, and stress-free. DeskIn helps families remotely: from troubleshooting...
DIFF Biotech's Innovative Nasal Spray Influenza Vaccine Receives Clinical Trial Approval, Introducing a New Attenuation Pathway
HANGZHOU, China, Feb. 9, 2026 /PRNewswire/ -- Zhejiang Difference Biological Technology Co., Ltd. (DIFF Biotech) announced that its proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, has recently received clinical trial approval as...
Coway Issues Official Response to Align Partners' Second Proposal, Reaffirms Commitment to Shareholders and Sustainable Growth
Coway proves record-breaking growth through core strategies led by Chairman Junhyuk Bang The company is also strengthening transparency in 2026 with the introduction of an Internal Transaction Committee and Lead Independent Director system Coway...
NX Taiwan Opens Tainan NEXT11 Warehouse as New Logistics Hub
- Aims to Bolster Supply Chains in Southern Taiwan to Accommodate Expanded Semiconductor and AI-related Operations - TOKYO , Feb. 9, 2026 /PRNewswire/ -- Nippon Express (Taiwan) Co., Ltd., (hereinafter NX Taiwan), a group company of NIPPON EXPRESS...
LakeShore Biopharma Announces Receipt of Buyer Group Notice and Postponement of Extraordinary General Meeting of Shareholders
BEIJING, Feb. 6, 2026 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new...
Kelun-Biotech Announces Fourth Indication for Sacituzumab Tirumotecan (sac-TMT) Approved by NMPA in HR+/HER2- Breast Cancer
CHENGDU, China, Feb. 6, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that a new indication application for its TROP2-directed ADC sacituzumab tirumotecan (sac-TMT, also...
PharmaResearch Receives U.S. FDA Clearance to Initiate Phase 1 Clinical Trial of Nano Anticancer Drug, PRD-101
SEONGNAM, South Korea, Feb. 6, 2026 /PRNewswire/ -- PharmaResearch Co., Ltd. (CEO: Jihoon Sohn) today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for PRD-101, enabling the...